Skip to main content
SpringerLink
Log in

Principles of Medical Treatment

  • Chapter
Vulvar Disease

  • 1303 Accesses

Abstract

Acute and chronic vulvar conditions are noted in women throughout their life span. Several of these conditions, such as vulvar infections and intraepithelial neoplasia, have well-defined clinical pathways of treatment utilizing pharmacologic interventions that have been vetted through clinical trials. Others, such as vulvodynia, a chronic pain condition that has been recognized for over 100 years, continue to perplex clinicians regarding best options for pharmacologic intervention. This chapter will review the spectrum of pharmacologic interventions used in various vulvar conditions, with an emphasis on the ones used in the management of vulvodynia. Vulvodynia will be highlighted as it is a vulvar condition clinicians treat with scant data from clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. American College of Obstetricians and Gynecologists. Vulvar disorders. ACOG clinical updates in women’s health care. VIII ed. Washington, DC: ACOG; 2010. p. 36.

    Google Scholar 

  2. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-3):1–137.

    Google Scholar 

  3. Portman DJ, Gass ML, Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of a Women’s sexual health and the North American Menopause Society. Menopause. 2014;10:1063–8.

    Article  Google Scholar 

  4. Danby CS, Margesson LJ. Approach to the diagnosis and treatment of vulvar pain. Dermatol Ther. 2010;23:485–504.

    Article  Google Scholar 

  5. Shifren JL, Gass ML. The North American Menopause Society recommendations for clinical care of midlife women. Menopause. 2014;21(10):1038–62.

    Article  Google Scholar 

  6. Bornstein J, Goldstein AT, Stockdale CK, et al. 2015 ISSVD, ISSWSH and IPPS consensus terminology and classification of persistent vulvar pain and Vulvodynia. Obstet Gynecol. 2016;127(4):745–51.

    Article  Google Scholar 

  7. Harlow BL, Kunitz CG, Nguyen RHN, Rydell SA, Turner RM, MacLehose RF. Prevalence of symptoms consistent with a diagnosis of vulvodynia: population-based estimates from 2 geographic regions. Am J Obstet Gynecol. 2014;210:40.e1–8.

    Article  Google Scholar 

  8. Jasmin L, Tien D, Janni G, et al. Is noradrenaline a significant factor in the analgesic effect of antidepressants? Pain. 2003;106:3–8.

    Article  CAS  Google Scholar 

  9. Foster DC, Kotok MB, Huang L, et al. Oral desipramine and topical lidocaine for vulvodynia: a randomized controlled trial. Obstet Gynecol. 2010;116:583–93.

    Article  CAS  Google Scholar 

  10. Brown CS, Wan J, Bachmann G, et al. Self-management, amitriptyline, and amitriptyline plus triamcinolone in the management of vulvodynia. J Women’s Health. 2009;18:163–9.

    Article  Google Scholar 

  11. Reed BD, Caron AM, Gorenflo DW, et al. Treatment of vulvodynia with tricyclic antidepressants: efficacy and associated factors. J Low Genit Tract Dis. 2006;10:245–51.

    Article  Google Scholar 

  12. De Andres J, Sanchis-Lopez N, Asensio-Samper JM, et al. Vulvodynia—an evidence-based literature review and proposed treatment algorithm. Pain Pract. 2015;16(2):204–36.

    Article  Google Scholar 

  13. Pagano R, Wong S. Use of amitriptyline cream in the management of entry dyspareunia due to provoked vestibulodynia. J Low Genit Tract Dis. 2012;16:394–7.

    Article  Google Scholar 

  14. Nyirjesy P, Lev-Sagie A, Mathew L, Culhane JF. Topical amitriptyline-baclofen cream for the treatment of provoked vestibulodynia. J Low Genit Tract Dis. 2009;13:230–6.

    Article  Google Scholar 

  15. Rogawski MA, Loscher W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med. 2004;10:685–92.

    Article  CAS  Google Scholar 

  16. Boardman LA, Cooper AS, Blais LR, Raker CA. Topical gabapentin in the treatment of localized and generalized vulvodynia. Obstet Gynecol. 2008;112:579–85.

    Article  Google Scholar 

  17. Brown CS, Foster DC, Wan JY, Rawlinson L, Bachmann GA, GABA Study Group. Rationale and design of a multicenter randomized clinical trial of extended release gabapentin in provoked vestibulodynia and biological correlates of response. Contemp Clin Trials. 2013;36:154–65.

    Article  Google Scholar 

  18. Cummins TR. Setting up for the block: the mechanism underlying lidocaine’s use-dependent inhibition of sodium channels. J Physiol. 2007;582(Pt 1):11.

    Article  CAS  Google Scholar 

  19. Zolnoun DA, Hartmann KE, Steege JF. Overnight 5% lidocaine ointment for treatment of vulvar vestibulitis. Obstet Gynecol. 2003;102:84–7.

    CAS  PubMed  Google Scholar 

  20. Danielsson I, Torstensson T, Brodda-Jansen G, Bohm-Starke N. EMG biofeedback versus topical lidocaine gel: a randomized study for the treatment of women with vulvar vestibulitis. Acta Obstet Gynecol Scan. 2006;85:1360–7.

    Article  Google Scholar 

  21. Rapkin AJ, McDonald JS, Morgan M. Multilevel local anesthetic nerve blockade for the treatment of vulvar vestibulitis syndrome. Amer J Obstet Gynecol. 2008;198:41.e1–5.

    Article  Google Scholar 

  22. McDonald JS, Rapkin AJ. Multilevel local anesthetic nerve blockade for the treatment of generalized vulvodynia: a pilot study. J Sex Med. 2012;9:2919–26.

    Article  Google Scholar 

  23. Murina F, Tassan P, Roberti P, Bianco V. Treatment of vulvar vestibulitis with submucous infiltrations of methylprednisolone and lidocaine: an alternative approach. J Reprod Med. 2001;46:713–6.

    CAS  PubMed  Google Scholar 

  24. Tympanidis P, Casula MA, Yiangou Y, Terenghi G, Dowd P, Anand P. Increased vanilloid receptor VR1 innervation in vulvodynia. Eur J Pain. 2004;8:129–33.

    Article  CAS  Google Scholar 

  25. Murina F, Radici G, Bianco V. Capsaicin and the treatment of vulvar vestibulitis syndrome: a valuable alternative? Med Gen Med. 2004;6:48.

    Google Scholar 

  26. Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin a reduces formalin-induced pain. Pain. 2004;107:125–33.

    Article  CAS  Google Scholar 

  27. Petersen CD, Giraldi A, Lundvall L, Kristensen E. Botulinum toxin type A—a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study. J Sex Med. 2009;6:2523–37.

    Article  CAS  Google Scholar 

  28. Pelletier F, Parratte B, Penze S, Moreno JP, Aubin F, Humbert P. Efficacy of high doses of botulinum toxin a for treating provoked vestibulodynia. Brit J Dermatol. 2011;164:617–22.

    CAS  Google Scholar 

  29. Foster DC, Hadsday JD. Elevated tissue levels of interleukin-1 beta and tumor necrosis factor-alpha in vulvar vestibulitis. Obstet Gynecol. 1997;89:291–6.

    Article  CAS  Google Scholar 

  30. Snyder DS, Unanue ER. Corticosteroids inhibit murine macrophage 1a expression and interleukin 1 production. J Immunol. 1982;129:1803–5.

    CAS  PubMed  Google Scholar 

  31. Munday PE. Treatment of vulval vestibulitis with a potent topical steroid. Sex Transm Infect. 2004;80:154–5.

    Article  CAS  Google Scholar 

  32. Desrochers G, Bergeron S, Khalife S, Dupuis M-J, Jodoin M. Provoked vestibulodynia: psychological predictors of topical and cognitive-behavioral treatment outcome. Behav Res Ther. 2010;48:106–15.

    Article  Google Scholar 

  33. Kieseier BC. The mechanism of action of interferon-β in relapsing multiple sclerosis. CNS Drugs. 2011;25:491–502.

    Article  CAS  Google Scholar 

  34. Bornstein J, Abramovici H. Combination of subtotal perineoplasty and interferon for the treatment of vulvar vestibulitis. Gynecol Obstet Investig. 1997;44:53–6.

    Article  CAS  Google Scholar 

  35. Marinoff SC, Turner ML, Hirsch RP, Richard G. Intralesional alpha interferon: cost effective therapy for vulvar vestibulitis syndrome. J Reprod Med. 1993;38:19–24.

    CAS  PubMed  Google Scholar 

  36. Nyirjesy P, Sobel JD, Weitz MV, Leaman DJ, Small MJ, Gelone SP. Cromolyn cream for recalcitrant idiopathic vulvar vestibulitis: results of a placebo-controlled study. Sex Transm Inf. 2001;77:53–7.

    Article  CAS  Google Scholar 

  37. Donders GG, Bellen G. Cream with cutaneous fibroblast lysate for the treatment of provoked vestibulodynia: a double-blind randomized placebo-controlled crossover study. J Lower Genital Tract Dis. 2012;16:427–36.

    Article  Google Scholar 

  38. Kamdar N, Fisher L, MacNeill C. Improvement in vulvar vestibulitis with montelukast. J Reprod Med. 2007;52:912–6.

    PubMed  Google Scholar 

  39. Farajun Y, Zarfati D, Abramov L, Livoff A, Bornstein J. Enoxaparin treatment of vulvodynia. A randomized controlled trial. Obstet Gynecol. 2012;120:565–73.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Tennessee Health Science Center, Memphis, TN, USA

    Candace S. Brown & Candi C. Bachour

  2. Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA

    Gloria A. Bachmann

Authors
  1. Candace S. Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Candi C. Bachour
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gloria A. Bachmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Candace S. Brown .

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology Galilee Medical Center, Bar-Ilan University Faculty of Medicine, Nahariya, Israel

    Jacob Bornstein

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Cite this chapter

Brown, C.S., Bachour, C.C., Bachmann, G.A. (2019). Principles of Medical Treatment. In: Bornstein, J. (eds) Vulvar Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-61621-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-61621-6_6

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-61620-9

  • Online ISBN: 978-3-319-61621-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation